Compare Moderna, Inc. (MRNA) vs Roundhill NVDA WeeklyPay ETF (NVDW) Price & Performance

Moderna, Inc.Trade

Roundhill NVDA WeeklyPay ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Roundhill NVDA WeeklyPay ETF — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Roundhill NVDA WeeklyPay ETF trades at $36. The key difference: Moderna, Inc. is trading nearer its 52-week high, Roundhill NVDA WeeklyPay ETF nearer its low. Which is the better fit depends on your goals.

	MRNA	NVDW
Market Cap	$23.60B	—
Sector	Health	Income / Options Overlay
52-Week High	$81.80	$53.42
52-Week Low	$22.36	$31.88
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

NVDW

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Roundhill NVDA WeeklyPay ETF

NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.